1. Home
  2. ISTR vs GBIO Comparison

ISTR vs GBIO Comparison

Compare ISTR & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Investar Holding Corporation

ISTR

Investar Holding Corporation

HOLD

Current Price

$27.20

Market Cap

256.3M

Sector

Finance

ML Signal

HOLD

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.43

Market Cap

35.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ISTR
GBIO
Founded
2006
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
256.3M
35.4M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
ISTR
GBIO
Price
$27.20
$5.43
Analyst Decision
Buy
Buy
Analyst Count
1
4
Target Price
$29.00
$10.67
AVG Volume (30 Days)
34.5K
40.1K
Earning Date
01-22-2026
11-05-2025
Dividend Yield
1.62%
N/A
EPS Growth
24.14
N/A
EPS
2.22
N/A
Revenue
$93,426,000.00
$15,270,000.00
Revenue This Year
$7.24
N/A
Revenue Next Year
$70.19
N/A
P/E Ratio
$12.23
N/A
Revenue Growth
12.93
N/A
52 Week Low
$15.39
$3.00
52 Week High
$27.42
$13.00

Technical Indicators

Market Signals
Indicator
ISTR
GBIO
Relative Strength Index (RSI) 81.27 51.71
Support Level $26.04 $5.22
Resistance Level $26.33 $5.64
Average True Range (ATR) 0.54 0.25
MACD 0.22 0.05
Stochastic Oscillator 93.22 67.19

Price Performance

Historical Comparison
ISTR
GBIO

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: